A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones

Year Published: 2011

Published In: European Journal of Endocrinology

Sample: 1331 (966 trans-women and 365 trans-men).

Conclusion: "The increased mortality in hormone-treated MtF transsexuals was mainly due to non-hormone-related causes, but ethinyl estradiol may increase the risk of cardiovascular death. In the FtM transsexuals, use of testosterone in doses used for hypogonadal men seemed safe."

DOI: 10.1530/EJE-10-1038

Fulltext: A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones

Authors

Raw Bibtex

@article{asscheman2011long,
  title={A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones},
  author={Asscheman, Henk and Giltay, Erik J and Megens, Jos AJ and Van Trotsenburg, Michael AA and Gooren, Louis JG},
  journal={European Journal of Endocrinology},
  volume={164},
  number={4},
  pages={635--642},
  year={2011},
  publisher={EFES},
  doi={10.1530/EJE-10-1038},
  fulltext={http://eje-online.org/content/164/4/635.long},
  sample={1331 (966 trans-women and 365 trans-men).},
  conclusion={"The increased mortality in hormone-treated MtF transsexuals was mainly due to non-hormone-related causes, but ethinyl estradiol may increase the risk of cardiovascular death. In the FtM transsexuals, use of testosterone in doses used for hypogonadal men seemed safe."}
}